Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Literature DB >> 17329188

Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Richard Greil, Hubert J Stein.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17329188 DOI： 10.1016/S1470-2045(07)70053-0

Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Neoadjuvant treatment of esophageal cancer.

Authors: Nicholas P Campbell; Victoria M Villaflor
Journal: World J Gastroenterol Date: 2010-08-14 Impact factor: 5.742

2. Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.

Authors: Elif Hindié; Christophe Hennequin; Jean-luc Moretti
Journal: Eur J Nucl Med Mol Imaging Date: 2007-10 Impact factor: 9.236

3. Towards an optimal treatment strategy for patients with oesophageal cancer.

Authors: Javier Gallego Plazas; Vanesa Pons Sanz
Journal: Clin Transl Oncol Date: 2008-03 Impact factor: 3.405

Review 4. Multidisciplinary approach for patients with esophageal cancer.

Authors: Victoria M Villaflor; Marco E Allaix; Bruce Minsky; Fernando A Herbella; Marco G Patti
Journal: World J Gastroenterol Date: 2012-12-14 Impact factor: 5.742

5. An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

Authors: Tarik Ghadban; Magdalena Schmidt-Yang; Magdalena Smif; Faik G Uzunoglu; Daniel R Perez; Tung Y Tsui; Alexander T El Gammal; Peter J Erbes; Veacheslav Zilbermints; Ulrich Wellner; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal: J Hum Genet Date: 2014-10-30 Impact factor: 3.172

Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Review 1. Neoadjuvant treatment of esophageal cancer.

2. Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.

3. Towards an optimal treatment strategy for patients with oesophageal cancer.

Review 4. Multidisciplinary approach for patients with esophageal cancer.

5. An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

6. Gastroesophageal reflux disease: From heartburn to cancer.

Review 7. [Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett's cancer].

Review 8. Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.